What is Thermo Fisher Scientific Inc. Annual Revenue?

Thermo Fisher Scientific Inc. Annual Revenue rose 0.05%, in the last year to $42,879 M. Its sector's average revenue growth for the last fiscal year was 8.57%.

What is Thermo Fisher Scientific Inc. Annual Net Profit?

Thermo Fisher Scientific Inc. Annual Net Profit rose 5.67% in the last year to $6,335 M. Its sector's average net profit growth for the last fiscal year was 4.36%.

What is Thermo Fisher Scientific Inc. Price to Earning Ratio?

Thermo Fisher Scientific Inc. Price to Earning Ratio is 25.9, lower than its sector PE ratio of 29.32.

What is Thermo Fisher Scientific Inc. Stock Price?

Thermo Fisher Scientific Inc. Stock Price fell 20.2% and underperformed its sector by 27.91% in the past year.

What is Thermo Fisher Scientific Inc. Quarterly Revenue?

Thermo Fisher Scientific Inc. Quarterly Revenue rose 4.68% YoY to $11,395 M. Its sector's average revenue growth YoY for the quarter was 8.5%.

What is Thermo Fisher Scientific Inc. Quarterly Net profit?

Thermo Fisher Scientific Inc. Quarterly Net profit rose 12.27% YoY to $1,830 M. Its sector's average net profit growth YoY for the quarter was 32.9%.

What is Thermo Fisher Scientific Inc. Debt to Equity Ratio?

Thermo Fisher Scientific Inc. Debt to Equity Ratio of 0.63 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Thermo Fisher Scientific Inc. Return on Equity(ROE)?

Thermo Fisher Scientific Inc. Return on Equity(ROE) for the last financial year was 13.15%, in the normal range of 10% to 20%.

What is Thermo Fisher Scientific Inc. Mutual Fund Holding?

Thermo Fisher Scientific Inc. Mutual Fund Holding increased by 0.19% in the last quarter to 70.37.

What is Thermo Fisher Scientific Inc. Promoter Share Holding?

Thermo Fisher Scientific Inc. Promoter Share Holding increased by 0.02% in the most recent quarter to 0.13%.

What is Thermo Fisher Scientific Inc. Interest Coverage Ratio?

Thermo Fisher Scientific Inc. Interest Coverage Ratio is 6.06, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).

What is Thermo Fisher Scientific Inc. Institutional Holding?

Thermo Fisher Scientific Inc. Institutional Holding increased by 0.78% in the last quarter to 92.55.

How is the Thermo Fisher Scientific Inc. today?

The Thermo Fisher Scientific Inc. today is trading in the green, up by 3.05% at 434.73.

How has Thermo Fisher Scientific Inc. performed historically?

The Thermo Fisher Scientific Inc. is currently trading up 3.05% on an intraday basis in the past week the index fell -3.25%. The index has been down -24.14% in the past quarter and fell -20.20% in the past year. You can view this in the overview section.

Thermo Fisher Scientific Inc. XNYS: TMO

Thermo Fisher Scientific Inc. Live Share Price Today, Share Analysis and Chart

Name: Thermo Fisher Scientific Inc.: Is Infosys Ltd. worth buying?
Item: Thermo Fisher Scientific Inc.
Rating: 2.541625125
Author: Trendlyne DVM scores

Falling Comet

Download real time

434.73 12.88 (3.05%)

30.76% Fall from 52W High

3.2M XNYS Volume

XNYS 22 Apr, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Thermo Fisher Scientific Inc. is on 24 Apr 2025 for the purpose of Thermo Fisher Scientific Inc First Quarter Earnings Results for 2025 See details

Thermo Fisher Scientific Inc. Key Metrics

My Metrics

Default

Market Capitalization High in industry Unavailable in chosen country	164,107.2
PE TTM High in industry Unavailable in chosen country	25.9
PEG TTM High in industry Unavailable in chosen country	4.6
Price to Book Below industry Median Unavailable in chosen country	3.3
Institutional holding current Qtr % Below industry Median Unavailable in chosen country	92.5
Revenue Growth Qtr YoY % Below industry Median Unavailable in chosen country	4.7
Operating Revenue growth TTM % Below industry Median Unavailable in chosen country	0.1
Net Profit Qtr Growth YoY % Below industry Median Unavailable in chosen country	12.3
Net Profit TTM Growth % Below industry Median Unavailable in chosen country	5.7
Operating Profit Margin Qtr % High in industry Unavailable in chosen country	19.7
Operating Profit Margin TTM % High in industry Unavailable in chosen country	18
Piotroski Score High in industry Unavailable in chosen country	7
Rel Perf vs Sector quarter% Unavailable in chosen country	-15.4
ROE Annual % High in industry Unavailable in chosen country	13.2
RoA Annual % High in industry Unavailable in chosen country	6.5

All financials are in USD Million and price data in USD

High Financial Strength

66.7 / 100

Mid Valuation

40.7 / 100

Technically Bearish

29.3 / 100

Falling Comet These stocks are the ones with good quality and mid-range financial aspects. However, their weak technical aspect reduces the investor's interest. View Similar Embed DVM

628

1Yr Price target upside is 45%

28 analysts

Check Before You Buy

Check P/E Buy Sell Zone

Strong Buy Zone

9.0 % into P/E buy sell zone

Strong upside potential

% time spent below current P/E

Gains already realized

Thermo Fisher Scientific Inc. Stock Price Analysis

Day Price Range 3.0% 1 Day return Unavailable in chosen country	434.7 (LTP) 426.5437 LowHigh
Week Price Range -3.2% 1 Week return Unavailable in chosen country	434.7 (LTP) 416.6450.3 LowHigh
Month Price Range -16.0% 1 Month return Unavailable in chosen country	434.7 (LTP) 409.8526.8 LowHigh
52 Week Price Range -20.2% 1 Year return Unavailable in chosen country	434.7 (LTP) 409.8627.9 LowHigh

View full Share Price History

Thermo Fisher Scientific Inc. Live Price Chart

Switch to TradingView

Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Hit

Thermo Fisher Scientific Inc.'s Revenue was higher than average estimate 3 times in past 3 years

EPS forecast

QUARTER
ANNUAL

Current EPS

16.5

Avg. Estimate

18.1

Low Estimate

16.3

High Estimate

19.3

Current EPS

Avg. Estimate

Hit

EPS is expected to grow by 9.7% in FY25

Consensus Recommendation

31 ANALYST Recommendations

BUY

The consensus recommendation from 31 analysts for Thermo Fisher Scientific Inc. is BUY

Forecaster is a Premium Feature

You need to upgrade your subscription plan to access this feature

Upgrade Now

Thermo Fisher Scientific Inc. Stock Analysis

Thermo Fisher Scientific Inc. stock analysis with key metrics, changes, and trends.

Thermo Fisher Scientific Inc. Metric	VALUE	CHANGE %	TREND	ANALYSIS
Annual Revenue	$42,879 M	0.05%	positive	Annual Revenue rose 0.05%, in the last year to $42,879 M. Its sector's average revenue growth for the last fiscal year was 8.57%.
Annual Net Profit	$6,335 M	5.67%	positive	Annual Net Profit rose 5.67% in the last year to $6,335 M. Its sector's average net profit growth for the last fiscal year was 4.36%.
Price to Earning Ratio	25.9	-	positive	Price to Earning Ratio is 25.9, lower than its sector PE ratio of 29.32.
Stock Price	$434.73	-20.2%	negative	Stock Price fell 20.2% and underperformed its sector by 27.91% in the past year.
Quarterly Revenue	$11,395 M	4.68%	positive	Quarterly Revenue rose 4.68% YoY to $11,395 M. Its sector's average revenue growth YoY for the quarter was 8.5%.
Quarterly Net profit	$1,830 M	12.27%	positive	Quarterly Net profit rose 12.27% YoY to $1,830 M. Its sector's average net profit growth YoY for the quarter was 32.9%.
Debt to Equity Ratio	0.63	-	positive	Debt to Equity Ratio of 0.63 is less than 1 and healthy. This implies that its assets are financed mainly through equity.
Return on Equity(ROE)	13.15 %	13.15%	neutral	Return on Equity(ROE) for the last financial year was 13.15%, in the normal range of 10% to 20%.
Mutual Fund Holding	70.37 %	0.19%	positive	Mutual Fund Holding increased by 0.19% in the last quarter to 70.37.
Promoter Share Holding	0.13 %	0.02%	positive	Promoter Share Holding increased by 0.02% in the most recent quarter to 0.13%.
Interest Coverage Ratio	6.06	-	positive	Interest Coverage Ratio is 6.06, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).
Institutional Holding	92.55 %	0.78%	positive	Institutional Holding increased by 0.78% in the last quarter to 92.55.

VIEW LESS

Loading data..

Thermo Fisher Scientific Inc. - Company Profile

What does Thermo Fisher Scientific Inc. do?

Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year end-2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (54%).

Year

Thermo Fisher Scientific Inc. Board of directors

All Gross Remunerations are in USD

Ms. Karen S. Lynch

Director

2025

Gross Remuneration

Year

Thermo Fisher Scientific Inc. Live Share Price Today, Share Analysis and Chart

30.76% Fall from 52W High

Thermo Fisher Scientific Inc. Key Metrics

Market Capitalization

PE TTM

PEG TTM

Rel Perf vs Sector quarter%

Price to Book

Institutional holding current Qtr %

Revenue Growth Qtr YoY %

ROE Annual %

Operating Revenue growth TTM %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

RoA Annual %

Operating Profit Margin Qtr %

Operating Profit Margin TTM %

Piotroski Score

Market Capitalization

PE TTM

PEG TTM

Price to Book

Institutional holding current Qtr %

Revenue Growth Qtr YoY %

Operating Revenue growth TTM %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

Operating Profit Margin Qtr %

Operating Profit Margin TTM %

Piotroski Score

Rel Perf vs Sector quarter%

ROE Annual %

RoA Annual %

SWOT Analysis

Check Before You Buy

Check P/E Buy Sell Zone

Thermo Fisher Scientific Inc. Stock Price Analysis

Day Price Range

Week Price Range

Month Price Range

52 Week Price Range

Thermo Fisher Scientific Inc. Live Price Chart

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Thermo Fisher Scientific Inc.'s Revenue was higher than average estimate 3 times in past 3 years

EPS forecast

EPS is expected to grow by 9.7% in FY25

Consensus Recommendation

The consensus recommendation from 31 analysts for Thermo Fisher Scientific Inc. is BUY

Thermo Fisher Scientific Inc. Stock Analysis

Thermo Fisher Scientific Inc. stock analysis with key metrics, changes, and trends.

Annual Revenue rose 0.05%, in the last year to $42,879 M. Its sector's average revenue growth for the last fiscal year was 8.57%.

Annual Net Profit rose 5.67% in the last year to $6,335 M. Its sector's average net profit growth for the last fiscal year was 4.36%.

Price to Earning Ratio is 25.9, lower than its sector PE ratio of 29.32.

Stock Price fell 20.2% and underperformed its sector by 27.91% in the past year.

Quarterly Revenue rose 4.68% YoY to $11,395 M. Its sector's average revenue growth YoY for the quarter was 8.5%.

Quarterly Net profit rose 12.27% YoY to $1,830 M. Its sector's average net profit growth YoY for the quarter was 32.9%.

Debt to Equity Ratio of 0.63 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

Return on Equity(ROE) for the last financial year was 13.15%, in the normal range of 10% to 20%.

Mutual Fund Holding increased by 0.19% in the last quarter to 70.37.

Promoter Share Holding increased by 0.02% in the most recent quarter to 0.13%.

Interest Coverage Ratio is 6.06, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).

Institutional Holding increased by 0.78% in the last quarter to 92.55.

Thermo Fisher Scientific Inc. - Company Profile

What does Thermo Fisher Scientific Inc. do?

Thermo Fisher Scientific Inc. Management structure

Mr. Marc N. Casper

Chairman of the Board, President and Chief Executive Officer

Mr. Michel Lagarde

Executive Vice President and Chief Operating Officer

Mr. Gianluca Pettiti

Executive Vice President

Mr. Stephen Williamson

Senior Vice President and Chief Financial Officer

Mr. Frederick M. Lowery

Executive Vice President

Mr. Michael A. Boxer

Senior Vice President and General Counsel

Thermo Fisher Scientific Inc. Board of directors

Ms. Karen S. Lynch